We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tonsillectomy Found Effective in Adults

By HospiMedica staff writers
Posted on 22 May 2007
Tonsillectomy is an effective remedy for adults with recurrent bouts of group A streptococcal pharyngitis, according to a new study.

Researchers at the University of Oulu (Finland) enrolled 70 adults in a randomized prospective study of adults with recurrent streptococcal pharyngitis (defined as three or more episodes in six months or four episodes in a year). More...
The study wished to examine the effectiveness of tonsillectomy in adults. Thirty-six patients were randomized to immediate surgery, and 34 remained on the waiting list as controls. The primary outcome was the percentage change in the risk of an episode of streptococcal pharyngitis at 90 days.

The results showed that tonsillectomy sharply reduced the number of acute episodes of pharyngitis, compared with watchful waiting. There were no serious adverse effects other than about two weeks of throat pain after the surgery. At 90 days, streptococcal pharyngitis had recurred in eight of the control patients (24%). One patient (3%) in the tonsillectomy group had a recurrence. The mean number of medical consultations for pharyngitis was 0.9 in the control group and 0.1 in the tonsillectomy group. The mean number of episodes of pharyngitis was 2.1 in the control group and 0.6 in the tonsillectomy group. The controls also had significantly more days with sore throat and fever, and rhinitis was higher, but not significantly so. The study was published in the May 5, 2007 issue of the British Medical Journal (BMJ).

Traditionally, tonsillectomy has been used to prevent recurrent streptococcal throat infections,” concluded lead author Olli-Pekka Alho, M.D., Ph.D., from the University of Oulu, and colleagues. "We think that the immediate effect of tonsillectomy reflects its overall usefulness.”


Related Links:
University of Oulu

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.